New report shows workforce being hit hard by diabetic eye disease 28 April 2015 The productivity of Australia’s workforce is being hit hard and may be even more so in the future by the impact of diabetic macular oedema (DME), according to a new report supported by Macular Disease Foundation Australia and Diabetes Australia. Key points: This year alone diabetic macular oedema (DME) is estimated to cost the country $2.07 billion in indirect economic costs, with a significant part due to reduced ability to work at full capacity and lost wellbeing caused by impaired vision.1 The impact is set to grow in coming years as the number of people living with diabetes is estimated to reach 2.45 million by 2030 and the prevalence of DME is estimated to rise by 42 per cent over the next 15 years.
Partners 24 June 2026 Can you prevent type 2 diabetes? Why it’s not set in stone If type 2 diabetes runs in your family, it’s a question that tends to sit in the background: Is this inevitable for me? Continue Reading
News 19 June 2026 Diabetes Australia strengthens lived experience voices with revised Constitution Everything Diabetes Australia does – every investment, every policy, every service – is to support our diabetes community. Today, Diabetes... Continue Reading
Media releases 18 June 2026 Hope for Australians living with cystic fibrosis and diabetes as new research targets breakthrough treatment A leading diabetes and respiratory researcher is investigating whether a breakthrough cystic fibrosis treatment could change the course of a serious form of diabetes affecting Australians living with cystic fibrosis. Continue Reading
